1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Hu, H.T.
Chazin, W.J.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
330
473
484
10.1016/S0022-2836(03)00619-3
12842464
Unique Features in the C-terminal Domain Provide Caltractin with Target Specificity
2003
10.2210/pdb1oqp/pdb
pdb_00001oqp
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
1
1.0
8977.838
Caltractin
1
man
polymer
2501.003
Cell division control protein KAR1
1
syn
polymer
Centrin, 20 kDa calcium-binding protein
no
no
GSGERDSREEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDDNEIDEDEFIRIMKKTSLF
GSGERDSREEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDDNEIDEDEFIRIMKKTSLF
A
polypeptide(L)
no
no
KKRELIESKWHRLLFHDKK
KKRELIESKWHRLLFHDKK
B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Chlamydomonas
Escherichia
sample
3055
Chlamydomonas reinhardtii
562
Escherichia coli
BL21(DE3)PlysS
Plasmid
PET
database_2
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2003-06-24
1
1
2008-04-29
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
_struct_ref_seq_dif.details
RCSB
Y
RCSB
2003-03-10
REL
REL
The peptide consists of the cdc31p-binding domain from Kar1p, residues 239-257, and has been chemically synthesized using solid phase F-Moc chemistry. The sequence is naturally found in Saccharomyces cerevisiae (baker's yeast).
sample
structures with the least restraint violations,structures with the lowest energy
60
20
3D_15N-separated_NOESY
3D_13C-separated_NOESY
4D_13C-separated_NOESY
2D NOESY
3D 13C-F1-edited, 13C-F3-filtered NOESY
50mM KCl, 5mM CaCl2
7.0
ambient
298
K
the structures are based on a total of 1827 constraints, 1641 are NOE-derived
distance constraints, 134 dihedral angle constraints, 52 distance constraints
from hydrogen bonds.
torsion angle dynamics
1mM CRC-C U-15N,13C; 1.2mM K19 unlabeled.
5mM CaCl2, 25mM Tris, 50mM KCl, 90% H2O, 10% D2O
1mM CRC-C U-15N,13C; 1.2mM K19 unlabeled.
5mM CaCl2, 25mM Tris, 50mM KCl, 100% D2O
1mM CRC-C unlabeled; 1.2 mM K19 unlabeled.
5mM CaCl2, 25mM Tris, 50mM KCl, 90% H2O, 10% D2O
Bruker
collection
XwinNMR
2.6
Accelrys, San Diego, CA
processing
Felix
2000
Accelrys, San Diego, CA
data analysis
Felix
2000
Guntert, P., Mumenthaler, C. & Wuthrich, K.
structure solution
DYANA
1.5
Pearlman, D.A., Case, D.A., Caldwell, J.W., Ross, W.S., Cheatham III, T.E., DeBolt, S., Ferguson, D., Seibel, G., Kollman, P.
refinement
Amber
7.0
600
Bruker
DRX
800
Bruker
DRX
GLY
93
n
1
GLY
93
A
SER
94
n
2
SER
94
A
GLY
95
n
3
GLY
95
A
GLU
96
n
4
GLU
96
A
ARG
97
n
5
ARG
97
A
ASP
98
n
6
ASP
98
A
SER
99
n
7
SER
99
A
ARG
100
n
8
ARG
100
A
GLU
101
n
9
GLU
101
A
GLU
102
n
10
GLU
102
A
ILE
103
n
11
ILE
103
A
LEU
104
n
12
LEU
104
A
LYS
105
n
13
LYS
105
A
ALA
106
n
14
ALA
106
A
PHE
107
n
15
PHE
107
A
ARG
108
n
16
ARG
108
A
LEU
109
n
17
LEU
109
A
PHE
110
n
18
PHE
110
A
ASP
111
n
19
ASP
111
A
ASP
112
n
20
ASP
112
A
ASP
113
n
21
ASP
113
A
ASN
114
n
22
ASN
114
A
SER
115
n
23
SER
115
A
GLY
116
n
24
GLY
116
A
THR
117
n
25
THR
117
A
ILE
118
n
26
ILE
118
A
THR
119
n
27
THR
119
A
ILE
120
n
28
ILE
120
A
LYS
121
n
29
LYS
121
A
ASP
122
n
30
ASP
122
A
LEU
123
n
31
LEU
123
A
ARG
124
n
32
ARG
124
A
ARG
125
n
33
ARG
125
A
VAL
126
n
34
VAL
126
A
ALA
127
n
35
ALA
127
A
LYS
128
n
36
LYS
128
A
GLU
129
n
37
GLU
129
A
LEU
130
n
38
LEU
130
A
GLY
131
n
39
GLY
131
A
GLU
132
n
40
GLU
132
A
ASN
133
n
41
ASN
133
A
LEU
134
n
42
LEU
134
A
THR
135
n
43
THR
135
A
GLU
136
n
44
GLU
136
A
GLU
137
n
45
GLU
137
A
GLU
138
n
46
GLU
138
A
LEU
139
n
47
LEU
139
A
GLN
140
n
48
GLN
140
A
GLU
141
n
49
GLU
141
A
MET
142
n
50
MET
142
A
ILE
143
n
51
ILE
143
A
ALA
144
n
52
ALA
144
A
GLU
145
n
53
GLU
145
A
ALA
146
n
54
ALA
146
A
ASP
147
n
55
ASP
147
A
ARG
148
n
56
ARG
148
A
ASN
149
n
57
ASN
149
A
ASP
150
n
58
ASP
150
A
ASP
151
n
59
ASP
151
A
ASN
152
n
60
ASN
152
A
GLU
153
n
61
GLU
153
A
ILE
154
n
62
ILE
154
A
ASP
155
n
63
ASP
155
A
GLU
156
n
64
GLU
156
A
ASP
157
n
65
ASP
157
A
GLU
158
n
66
GLU
158
A
PHE
159
n
67
PHE
159
A
ILE
160
n
68
ILE
160
A
ARG
161
n
69
ARG
161
A
ILE
162
n
70
ILE
162
A
MET
163
n
71
MET
163
A
LYS
164
n
72
LYS
164
A
LYS
165
n
73
LYS
165
A
THR
166
n
74
THR
166
A
SER
167
n
75
SER
167
A
LEU
168
n
76
LEU
168
A
PHE
169
n
77
PHE
169
A
LYS
239
n
1
LYS
239
B
LYS
240
n
2
LYS
240
B
ARG
241
n
3
ARG
241
B
GLU
242
n
4
GLU
242
B
LEU
243
n
5
LEU
243
B
ILE
244
n
6
ILE
244
B
GLU
245
n
7
GLU
245
B
SER
246
n
8
SER
246
B
LYS
247
n
9
LYS
247
B
TRP
248
n
10
TRP
248
B
HIS
249
n
11
HIS
249
B
ARG
250
n
12
ARG
250
B
LEU
251
n
13
LEU
251
B
LEU
252
n
14
LEU
252
B
PHE
253
n
15
PHE
253
B
HIS
254
n
16
HIS
254
B
ASP
255
n
17
ASP
255
B
LYS
256
n
18
LYS
256
B
LYS
257
n
19
LYS
257
B
author_defined_assembly
2
dimeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
ILE
118
A
N
ILE
26
A
O
ILE
154
A
O
ILE
62
1
A
ARG
124
0.099
SIDE CHAIN
1
B
ARG
241
0.089
SIDE CHAIN
3
B
ARG
250
0.085
SIDE CHAIN
4
A
ARG
125
0.084
SIDE CHAIN
6
A
ARG
124
0.090
SIDE CHAIN
6
B
HIS
249
0.095
SIDE CHAIN
7
B
HIS
249
0.080
SIDE CHAIN
8
A
ARG
125
0.082
SIDE CHAIN
8
B
ARG
241
0.103
SIDE CHAIN
10
A
ARG
124
0.095
SIDE CHAIN
12
B
PHE
253
0.082
SIDE CHAIN
13
A
ARG
97
0.131
SIDE CHAIN
13
A
ARG
124
0.103
SIDE CHAIN
16
B
HIS
249
0.107
SIDE CHAIN
17
A
ARG
125
0.082
SIDE CHAIN
19
B
HIS
249
0.082
SIDE CHAIN
3
-3.33
0.50
120.30
116.97
B
B
B
NE
CZ
NH2
ARG
ARG
ARG
241
241
241
N
1
B
PHE
253
-77.66
37.82
1
B
ASP
255
-67.89
79.10
1
B
LYS
256
66.49
-70.63
2
A
ASP
98
43.92
-137.11
2
A
ASN
149
172.13
-57.33
2
A
ASP
150
79.60
57.00
2
A
ASN
152
75.57
-8.69
2
B
GLU
242
-29.56
-52.28
3
A
GLU
132
-66.58
92.07
3
B
HIS
254
-170.11
-47.41
3
B
ASP
255
46.29
-139.52
3
B
LYS
256
69.09
-62.72
4
A
ASP
98
36.95
-135.48
4
A
ASP
150
74.59
42.72
4
A
ASN
152
76.44
-3.71
4
B
GLU
242
-103.56
-89.17
4
B
PHE
253
-75.66
36.14
4
B
LYS
256
-69.17
72.80
5
A
ASP
150
76.02
38.01
5
A
ASN
152
71.21
32.82
6
A
ASP
150
75.91
33.14
7
A
SER
94
69.91
-60.43
7
A
GLU
96
-67.54
93.94
7
A
ASP
98
-115.14
-75.52
7
A
ASP
150
59.26
15.13
7
A
ASN
152
83.70
-15.35
7
B
HIS
254
33.44
-112.98
8
A
SER
99
-27.82
-42.13
8
A
GLU
132
-66.22
91.28
8
A
ASN
149
165.51
-49.72
8
A
ASP
150
74.45
59.39
8
B
LYS
240
74.54
-40.64
8
B
ASP
255
-175.56
-124.06
9
A
SER
94
-71.08
-72.92
9
A
ASP
98
-151.36
-68.39
9
A
GLU
132
-62.86
90.82
9
A
ASN
149
175.62
-109.99
9
A
ASP
150
-172.64
27.05
9
B
ARG
241
96.54
103.63
10
A
SER
94
-75.38
49.70
10
A
GLU
132
-60.00
97.56
10
A
ASP
150
74.67
35.37
10
B
ARG
241
-172.06
-44.60
11
A
SER
94
-73.40
40.35
11
A
ASN
152
85.65
-5.10
12
A
SER
99
71.12
-56.43
12
A
ASP
150
29.62
51.23
12
A
ASN
152
79.63
-15.70
12
B
LEU
252
-93.73
-72.99
12
B
LYS
256
66.79
-65.66
13
A
ARG
97
-69.59
72.16
13
A
ASP
150
84.39
13.95
13
B
LYS
240
41.12
-98.59
14
A
ASN
152
83.86
-8.94
14
B
ARG
241
67.62
-68.55
14
B
PHE
253
-74.00
34.34
14
B
ASP
255
69.08
-58.02
14
B
LYS
256
-68.47
75.56
15
A
ARG
97
-76.73
41.85
15
A
ASP
98
-102.09
-63.50
15
A
ASN
152
109.85
26.41
15
B
ARG
241
70.44
-58.72
15
B
PHE
253
-85.30
38.22
15
B
ASP
255
65.56
166.27
16
A
SER
94
-65.38
67.32
16
A
ASN
114
54.34
17.98
16
A
ASN
152
70.68
34.05
17
A
SER
94
-12.02
-76.03
17
A
ARG
97
-78.37
49.91
17
A
SER
115
-76.57
32.74
17
A
ALA
146
-101.03
-60.57
17
A
ASP
147
-58.20
103.41
17
A
ASN
152
103.10
17.80
18
A
SER
94
59.91
-152.73
18
A
ASP
150
75.55
38.18
18
B
PHE
253
-74.25
46.12
18
B
HIS
254
-164.57
88.41
20
A
GLU
132
-65.20
92.46
20
A
ASP
150
82.89
29.09
20
B
HIS
254
19.58
73.28
20
B
LYS
256
-68.83
80.20
STRUCTURE OF THE CA2+/C-TERMINAL DOMAIN OF CALTRACTIN IN COMPLEX WITH THE CDC31P-BINDING DOMAIN FROM KAR1P
1
N
N
2
N
N
A
ASP
98
A
ASP
6
HELX_P
A
ASP
111
A
ASP
19
1
1
14
A
ILE
120
A
ILE
28
HELX_P
A
GLY
131
A
GLY
39
1
2
12
A
THR
135
A
THR
43
HELX_P
A
ASP
147
A
ASP
55
1
3
13
A
ASP
155
A
ASP
63
HELX_P
A
THR
166
A
THR
74
1
4
12
B
LYS
239
B
LYS
1
HELX_P
B
PHE
253
B
PHE
15
1
5
15
PROTEIN BINDING
protein-peptide complex, caltractin, KAR1P, calcium-binding, PROTEIN BINDING
CATR_CHLRE
UNP
1
95
P05434
GERDSREEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDDNEIDEDEFIRIMKKTSLF
KAR1_YEAST
UNP
2
239
P11927
KKRELIESKWHRLLFHDKK
95
169
1OQP
95
169
P05434
A
1
3
77
239
257
1OQP
239
257
P11927
B
2
1
19
1
expression tag
GLY
93
1OQP
A
P05434
UNP
1
1
expression tag
SER
94
1OQP
A
P05434
UNP
2
2
anti-parallel
A
ILE
118
A
ILE
26
A
THR
119
A
THR
27
A
GLU
153
A
GLU
61
A
ILE
154
A
ILE
62